Synthesis and photochemical redox reactivity of an unsymmetrically substituted MnMn Bond: mer,fac-Mn2(CO)6(PMe2CH2PMe2)2

The reaction of Mn₂(CO)₁₀ with the diphosphine bis(dimethylphosphino)methane, dmpm, gives a mixture of two isomers: mer, fac-Mn₂(CO)₆(dmpm)₂, 1, and mer,mer-Mn₂(CO)₆(dmpm)₂, 2. Complex 1 is the first example of a bis(dmpm) complex with a cis,trans arrangement of the dmpm ligands. Both 1 and 2 can be thermally oxidized by one-electron to give the relatively stable binuclear radial cations [mer,fac-Mn₂(CO)₆(dmpm)₂]⁺, 3, and [mer,mer- Mn₂(CO)₆(dmpm)₂]⁺ , 4, respectively. The EPR spectra of 3 and 4 in THF indicate localization of unpaired spin density on one of the two Mn metal centers. The EPR of 4 in CH₂Cl₂ indicates delocalization of unpaired spin density over both Mn metal centers. The unsymmetrical isomer, 1, is a strong one-electron photoreductant. The excited state redox potential of 1, E° (3/1*), has been approximated to be −1.35 ⩽E° (3/1*)⩽−1.87 V vs. SCE. Under the same experimental conditions the symmetrical isomer 2 exhibits no photochemical redox behavior.     

Synthesis,antiproliferative and mitochondrial impairment activities of bis-alkyl-amino transplatinum complexes

A convenient synthetic route and the characterization of complexes trans-[PtCl₂(L)(PPh₃)] (L = Et₂NH (2), (PhCH₂)₂NH (3), (HOCH₂CH₂)₂NH) (4) are reported. The antiproliferative activity was evaluated on three human tumor cell lines. The investigation on the mechanism of action highlighted for the most active complex 4 the capacity to affect mitochondrial functions. In particular, both the induction of the mitochondrial permeability transition phenomenon and an aspecific membrane damage occurred, depending on concentration.     

Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis,characterization and biological properties

(p-Cymene)-ruthenium bioconjugates ML (1) and ML₂ (2), bearing phosphane ligands substituted with chiral or non-chiral amino acid esters, L, were synthetized and characterized by instrumental methods (NMR, CD, MS) and DFT calculations (using the wB97xD functional). Cytotoxic activity of complexes 1 and 2 was investigated by using human cervical carcinoma cell line (HeLa) and MTT assay. Four (2_pG, 2_pA, 2_mG and 2_mA) out of ten synthesized ruthenium complexes showed significant toxicity, with IC₅₀ values of 5–30 μM. Evaluation of the potential biomolecular targets of bioconjugates 2 by UV–Vis, fluorescence and CD spectroscopy revealed no measurable interaction with DNA, but micromolar affinity for proteins. The cytotoxicity of bioconjugates 2 is in correlation with their BSA binding constants, i. e. bioconjugates with lower IC₅₀ values show higher binding affinities towards BSA. Compound 2_mG with value of IC₅₀ 16 μM was selected for further biological characterization. The higher level of toxicity towards tumor compared to normal cell lines indicates its selective activity, important characteristic for potential medical use. It was detected 2_mG caused increase of cells in the S phase of cell cycle and consequential decrease of cells in G0/G1 phase. Additionally, 2_mG caused dose- and time-dependent increase of SubG0/G1 cell population, suggesting its ability to induce programmed cell death. Further investigation determined autophagy as the mode of cell death. The role of GSH in HeLa cells response to investigated organometallic ruthenium complexes was confirmed using specific regulators of GSH synthesis, buthionine sulfoximine and N-acetyl-cysteine. Pre-treatment of cells with ethacrynic acid and probenecid emphasized the role of GSH in detoxification of 2_mG compound. The amount of total ruthenium accumulation in the cell did not correlate with toxicity of 2_pG, 2_pA, 2_mG and 2_mA, suggesting structure dependent differences in either cell uptake or kinetics of ruthenium complexes detoxification. We speculate that ruthenium complexes bind protein-based biomolecules further triggering cell death. Based on the gained knowledge, the synthesis and development of more tumor-specific ruthenium-based complexes as potential anticancer drugs can be expected.     

Rhodium aryloxide complexes containing terdentate nitrogen ligands, C-O bond formation, hydrogen bonding with phenol and oxidative addition reactions. Molecular structure of an Rh(III)-acetyl complex

The new rhodium(I) phenoxide complexes [Rh(OPh) (2,6-(CH=R²)₂C₅H₃N)] (R² = i-Pr(3), t-Bu(4)) containing strongly electrondonating N-N′-N ligands, have been prepared by a metathesis reaction of [RhCl(2,6-(CH=R²)₂C₅H₃N)] (R² = i-Pr (1), t-Bu (2)) with NaOPh. These rhodium(I) phenoxide complexes 3 and 4, which are very sensitive to O₂ but stable towards H₂O, give with phenol the adducts [Rh(OPh) (2,6-(CH=NR²)₂C₅H₃N)] · HOPh (R2 = i-Pr (5), t-Bu (6)), which contain strong O-HO hydrogen bonds. The hydrogen bonded phenol could not be extracted with diethyl ether, while no exchange of the hydrogen bonded phenol and the phenoxide ligand in 4 is observed on the NMR time scale. However, a small excess of phenol results in exchange of the hydrogen bonded phenol, the coordinated phenoxide ligand and free phenol on the NMR time scale. Reaction of 3 and 4 with p-nitrophenol afforded [Rh(OC₆H₄-(NO₂-4))(2,6-(CH=R²)₂C₅H₃N)] · HOPh (R² = i-Pr (7), t-Bu (8)) in which the formed phenol is hydrogen bonded to the Rh(I)-OC₆H₄-(NO₂-4) moiety. The O-HO bond is less strong than in 5 and 6, as the hydrogen bonded phenol could be removed by diethyl ether.Treatment of 3 with acetyl chloride and benzoyl chloride in benzene at room temperature gave phenylacetate and RhCl₂(C(O)C₆H₃) (2,6(C(H)=N-i-Pr)₂C₅H₃N)] (15), and phenylbenzoate and [RhCl₂(C(O)Ph) (2,6-(C(H)=N-i-Pr)₂C₅H₃N)] (19), respectively. Complex 15 and the analogous complex [RhCl₂(C(O)CH₃) (2,6-(C(H)=N-t-Bu)₂C₅H₃N)] (16) could also be prepared directly from acetyl chloride and 1 or 2, respectively. The single crystal X-ray determination of complex 16, monoclinic, space group P2₁/_c, a = 10.0477(5), b= 11.7268(6), c= 19.2336(9) Å, β = 92.041(4)°, Z = 4, R₁ = 0.0281, shows that the acetyl group occupies an axial position, while the N-N′-N ligand is positioned equatorially. In solution this geometry remains unchanged as was shown by variable temperature ¹H NMR measurements. When the oxidative addition of acetyl chloride to 3 was carried out at −78°C in toluene the intermediate complex [RhCl(OPh) (C(O)Me) (2,6-(C(H)=N-i-Pr)₂C₅H₃N)] (11) could be isolated, which at room temperature reductively eliminates phenylacetate with formation of 1. Oxidative addition of acetyl chlori de to 4 at room temperature gives [RhCl(OPh) (C(O)Me) (2,6-(C(H)=Nt-Bu)₂C₅H₃N)] (12) which yields phenylacetate and 2 at 70°C in benzene by inductive elimination. Treatment of 3 with two equivalents of benzyl chloride afforded a mixture of [RhCl(OPh) (CH₂Ph) (2,6-(C(H)=N-i-Pr)₂C₅H₃N)] (13) and [RhCl₂(CH₂Ph) (2,6-(C(H)=N-i-Pr)₂C₅H₃N)] (17) and some non-characterizable organic products, while 4 only yielded [RhCl(OPh) (CH₂Ph) (2,6-(C(H)=N-tBu)₂C₅H₃N)] (14).     

Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives

A series of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives 4a₁–4n₂ were designed and synthesized based on the 2-oxo-quinoline structure core as novel antioxidants. In vitro antioxidant activities of these compounds were evaluated and compared with commercial antioxidants ascorbic acid, BHT and BHA, employing DPPH assay, ABTS⁺ assay, O₂^? assay and OH assay. The results showed that IC₅₀ of most compounds were lower than standard value 10 mg/mL, indicating good antioxidant activities of these compounds. In addition, in vitro antioxidant activities screening revealed that 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities of compounds 4b₂, 4e₁, 4e₂ and 4g₂, 2,2′-azinobis-(3-ethylbenzthiazoline-6-sulphonate) cation (ABTS⁺) radical scavenging activities of compounds 4a₁, 4e₁, 4e₂, 4f₁, 4f₂, 4g₁, 4g₂, 4h₁, 4h₂, 4k₁, 4k₂, 4n₁ and 4n₂, superoxide anion radical scavenging activities of 4b₁, 4e₁, 4f₂, 4j₁, 4k₁, 4k₂, 4m₁, 4m₂, and 4n₂, and hydroxyl radical scavenging activity of almost all the compounds except 4f₁, 4f₂, 4j₂, 4l₁ and 4l₂ were better than that of the commercial antioxidant butylated hydroxytoluene (BHT).     

Syntheses,structures and photoluminescent property of coordination complexes with 2-(1H-1,2,4-triazol-1-yl)acetic acid

Reactions of ligand 2-(1H-1,2,4-triazol-1-yl)acetic acid (HL) with varied metal salts of Cu(II), Co(II), Ni(II), Zn(II), Cd(II) and Ag(I) result in formation of six new coordination complexes, {[Cu(L)₂] · 3H₂O}_n (1), [Co(L)₂(H₂O)₂]_n (2), [Ni(L)₂(H₂O)₂]_n (3), [Zn(L)₂(H₂O)₂]_n, (4), [Cd(L)₂]_n (5) and [Ag(L)]_n (6), and their structures were determined by X-ray crystallography. Complexes 1, 2, 3 and 4 with square-planar or octahedral metal centers have similar two-dimensional (2D) network structure with (4, 4) topology, while complex 5 displays a 2D structure with (6, 3)-connected topology. Complex 6 has a three-dimensional (3D) structure, in which the Ag(I) has tetrahedral coordination geometry. Ligand L^? acts as a 2-connected rod (bridging ligand) in 1, 2, 3 and 4, and acts as 3-connected nodes in 5 and 6. The results indicate that the coordination modes of the ligand and metal centers have great influence on the structures of the complexes. In addition, the photoluminescent properties of ligand HL and complexes 4 and 5 were studied in the solid state at room temperature.     

Coordination chemistry of group 4 metal compounds with mixed-ligand,silyl-linked bis(amidinate) ligand and cyclopentadienyl

The synthesis and characterization of a class of group 4 metal derivatives based on the silyl-linked bis(amidinate) ligands [SiMe₂{NC(Ph)N(2,6-R₂Ph)Li}₂] [L¹ (R = H) and L² (R = Me)] are described. The metal salts coordinated with cyclopentadienyl were used in order to increase the steric hindrance and lower the Lewis acidity of metal centers, which could prevent the N-ligands from rearranging. The tetradentate ligands L¹ and L² reacted with TiCl₂(C₅H₅)₂ to give compounds 1 and 2 in tridentate and bidentate bonding modes, respectively. Treatment of the ligand L¹ with ZrCl₃(C₅H₅) produced the half-sandwich zirconium complex 3. Reactions of the ligands with ZrCl₂(C₅H₅)₂ afforded zirconium compounds 4 and 5, demonstrating the same geometry as 1. Comparing these analogous molecular structures, it suggests that the coordination modes of the N-ligands are variable according to the properties of the metal centers as well as the bulky hindrance of the terminal groups on the seven-membered N–C–N–Si–N–C–N backbone.     

Hydrogen and oxygen trapping at the H-cluster of [FeFe]-hydrogenase revealed by site-selective spectroscopy and QM/MM calculations

[FeFe]-hydrogenases are superior hydrogen conversion catalysts. They bind a cofactor (H-cluster) comprising a four-iron and a diiron unit with three carbon monoxide (CO) and two cyanide (CN^?) ligands. Hydrogen (H₂) and oxygen (O₂) binding at the H-cluster was studied in the C169A variant of [FeFe]-hydrogenase HYDA1, in comparison to the active oxidized (Hox) and CO-inhibited (Hox-CO) species in wildtype enzyme. ⁵⁷Fe labeling of the diiron site was achieved by in vitro maturation with a synthetic cofactor analogue. Site-selective X-ray absorption, emission, and nuclear inelastic/forward scattering methods and infrared spectroscopy were combined with quantum chemical calculations to determine the molecular and electronic structure and vibrational dynamics of detected cofactor species. Hox reveals an apical vacancy at Fe_d in a [4Fe4S-2Fe]^3 ? complex with the net spin on Fe_d whereas Hox-CO shows an apical CN^? at Fe_d in a [4Fe4S-2Fe(CO)]^3 ? complex with net spin sharing among Fe_p and Fe_d (proximal or distal iron ions in [2Fe]). At ambient O₂ pressure, a novel H-cluster species (Hox-O₂) accumulated in C169A, assigned to a [4Fe4S-2Fe(O₂)]^3 ? complex with an apical superoxide (O₂^?) carrying the net spin bound at Fe_d. H₂ exposure populated the two-electron reduced Hhyd species in C169A, assigned as a [(H)4Fe4S-2Fe(H)]^3 ? complex with the net spin on the reduced cubane, an apical hydride at Fe_d, and a proton at a cysteine ligand. Hox-O₂ and Hhyd are stabilized by impaired O₂^– protonation or proton release after H₂ cleavage due to interruption of the proton path towards and out of the active site.     

Synthesis and characterisation of pyrazolic palladium compounds containing alcohol functionality:: rotation around the Pd-N bond

The ligands 1-hydroxymethylpyrazole (hl¹), 1-(2-hydroxyethyl)pyrazole (hl²) and 1-(3-hydroxypropyl)pyrazole (hl³) react with [PdCl₂(CH₃CN)₂] to give trans-[PdCl₂(hl)₂] compounds. Due to a hindered rotation around the Pd-bond, these compounds present two different conformations in solution: anti and syn. The conformation presented depends on the relative disposition of the hydroxyalkylic chains of the two pyrazolic ligands. The present study was carried out on the basis of NMR experiments. The present paper reports the crystal structure of trans-[PdCl₂(hl²)₂]. The synthesis and characterisation of compounds [Pd(hl)₄](BF₄)₂ (hl = hl¹, hl² and hl³) starting from [Pd(CH₃CN)₄](BF₄)₂ and the corresponding chlorocomplexes trans-[PdCl₂(hl)₂] are also described.     

Trinuclear iridium and rhodium complexes: the solution to a puzzle involving the multiple coordination possibilities of 1,8-naphthyridine-2-one ligands

The multiple coordination possibilities of 1,8-naphthyridine-2-one (HOnapy) and 5,7-dimethyl-1,8-napthyridine-2-one (HOMe₂napy) ligands allow the synthesis of a variety of tri- di- and mononuclear complexes, showing fluxional behaviour and frequent exchange of the coordinated ML₂ fragments. Thus, reactions of [M₂(μ-OMe)₂(cod)₂] (cod = 1,5-cyclooctadiene) with HOnapy and HOMe₂napy yield the compounds of the general formula [M(μ-OR₂napy) (cod)]_n (M = Ir, R = Me (1a, 1b, H (2); M = Rh, R = Me (3a, 3b). They crystallise as inconvertible yellow (a) and purple/orange (b) forms and also show a puzzling behaviour in solution. X-ray diffraction studies on both forms (3a, 3b) and spectroscopic data reveal that the yellow forms are mononuclear complexes whilst the dark-coloured crystals contain dinuclear complexes. In solution, the nuclearity of the complexes depends on the solvent. In addition both types of complexes are fluxional. The mixed-ligand complexes [M₂(μ-OMe₂napy)₂(CO)₂(cod)] M = Ir (5), Rh (6) have been isolated and characterised; they are found to be intermediates in the synthesis of the trinuclear complexes [M₃(μ₃-OMe₂napy)₂(CO)₂(cod)₂]⁺ M = Rh (8), Ir (9). Reactions of [IrCl(CO)₂(NH₂-p-tolyl] with the complexes [Rh(μ-OR₂napy)(diolefin)]_n followed by addition of a poor donor anion is a general one-pot synthesis for the hetertrinuclear complexes [Rh₂Ir(μ₃-OR₂napy)₂(CO)₂(diolefin)₂]⁺ (R=Me, DIOLEFIN = cod (10), tetrafluorobenzo-barrelene (tfbb) (11), 2,5-norbornadiene (nbd) (12); R=H, DIOLEFIN=cod (13)). This synthesis follows a stepwise mechanism from the mononuclear to the trinuclear complexes in which mixed-ligand heterodinuclear complexes are involved as intermediates of the type [(diolefin)Rh(μ-OMe₂napy)₂Ir(CO)₂]. Heteronuclear complexes which possess the core [RhIr₂]³⁺, such as [RhIr₂(μ₃-OR₂napy)₂(CO)₂(cod)₂]BF₄ (R=Me (14), H (15)), result from the reaction of 1 or 2 with [Rh(CO)₂S_x]⁺ (S = solvent). The trinuclear complexes undergo two chemically reversible one-electron oxidation processes. The chemical oxidation of 10, 14 and 9 with silver salts gives the mixed-valence trinuclear radicals [Rh₂Ir(μ₃-OMe₂napy)₂(CO)₂(cod)₂]²⁺ (16), [RhIr₂(μ₃-OMe₂napy)₂(CO)₂(cod)₂]²⁺ (17) and [Ir₃(μ₃-OMe₂napy)₂(CO)₂(cod)₂]²⁺ (18), which have been isolated as the perchlorate and tetrafluoroborate salts. The EPR spectrum of 16 indicates that the unpaired electron is essentially in an orbital delocalised on the metals. The molecular structures of the complexes 3a, 3b, 6, 10b and 16a are described. Crystals of 3a are triclinic, P-1, with a = 9.7393(2), b = 14.0148(4), c = 16.0607(4) Å, α = 88.122(3), β = 83.924(3), γ = 87.038(3)°, Z = 4; 3b crystallises in the Pna2_i orthorhhombic space group, with a = 16.7541(3), B = 11.7500(8), c = 17.7508(7) Å, Z = 4; complex 6 is packed in the monoclinic space group P2_i/c, a = 9.6371(1), b = 11.8054(4), c = 27.2010(9) Å, β = 90.556(4)°, Z = 4; crystals of 10b are monoclinic, P2₁/n, with a = 17.546(7), b = 13.232(6), c = 17.437(8) Å, β = 106.18(1)°, Z = 4; crystals of 16a are triclinic, P-1, with a = 10.318(4), b = 12.562(6), C = 19.308(8) Å, α = 92.12(8), β = 97.65(9), γ = 90.68(5)°, Z = 2. The five different structures show the coordination versatility of the OMe₂napy molecule as ligand, which behaves as a N,N′-chelating (3a), bidentate N,O-donor (3b, 6), or as a tridentate N,N′,O-donor bridging ligand (10b, 16a).     

Bismuth(III) complexes with 2-acetylpyridine- and 2-benzoylpyridine-derived hydrazones: Antimicrobial and cytotoxic activities and effects on the clonogenic survival of human solid tumor cells

Complexes [Bi(2AcPh)Cl₂]·0.5H₂O (1), [Bi(2AcpClPh)Cl₂] (2), [Bi(2AcpNO₂Ph)Cl₂] (3), [Bi(2AcpOHPh)Cl₂]·2H₂O (4), [Bi(H2BzPh)Cl₃]·2H₂O (5), [Bi(H2BzpClPh)Cl₃] (6), [Bi(2BzpNO₂Ph)Cl₂]·2H₂O (7) and [Bi(H2BzpOHPh)Cl₃]·2H₂O (8) were obtained with 2-acetylpyridine phenylhydrazone (H2AcPh), its -para-chloro-phenyl- (H2AcpClPh), -para-nitro-phenyl (H2AcpNO₂Ph) and -para-hydroxy-phenyl (H2AcpOHPh) derivatives, as well as with the 2-benzoylpyridine phenylhydrazone analogues (H2BzPh, H2BzpClPh, H2BzpNO₂Ph, H2BzpOHPh).Upon coordination to bismuth(III) antibacterial activity against Gram-positive and Gram-negative bacterial strains significantly improved except for complex (4).The cytotoxic effects of the compounds under study were evaluated on HL-60, Jurkat and THP-1 leukemia, and on MCF-7 and HCT-116 solid tumor cells, as well as on non-malignant Vero cells. In general, 2-acetylpyridine-derived hydrazones proved to be more potent and more selective as cytotoxic agents than the corresponding 2-benzoylpyridine-derived counterparts.Exposure of HCT-116 cells to H2AcpClPh, H2AcpNO₂Ph and complex (3) led to 99% decrease of the clonogenic survival. The IC₅₀ values of these compounds were three-fold smaller when cells were cultured in soft-agar (3D) than when cells were cultured in monolayer (2D), suggesting that they constitute interesting scaffolds, which should be considered in further studies aiming to develop new drug candidates for the treatment of colon cancer.     

Asperidines A–C,pyrrolidine and piperidine derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178

One new pyrrolidine derivative, asperidine A (1), and two new piperidine derivatives, asperidines B (2) and C (3), were isolated from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 together with two known alkaloids. Compound 3 possessed an unprecedented 7-oxa-1-azabicyclo[3.2.1]octane skeleton with four chiral centers. Their structures were determined by spectroscopic evidence. The absolute configurations of compounds 2 and 3 were established using Mosher’s method and further confirmed for compound 3 by X-ray crystallographic data. Compound 2 dose-dependently inhibited the CFTR-mediated chloride secretion in T84 cells with an IC₅₀ value of 0.96?μM whereas 3 displayed the same activity with the IC₅₀ value of 58.62?μM. Compounds 2 and 3 also significantly reduced intracellular ROS under both normal and H₂O₂-treated conditions compared with their respective controls in a dose-dependent manner without cytotoxic effect on Caco-2 cells. In addition, compound 3 was inactive against noncancerous Vero cells whereas compound 2 was considered to be inactive with the IC₅₀ value of >10?μM.     

Interactions of platinum—1-methyluracil blue and its hydrolysis products with DNA

The preparation of Pt(NH₃)₂(MeU)₂·2H₂O, 1. [(NH₃)₂Pt(MeU)₂Pt(NH₃)₂](NO₃)₂, 2. Pt(NH₃)₂Cl(MeU), 3. and (in solution) [Pt(NH₃)₂(OH)(MeU)], 4. (MeU = 1-methyluracil monoanion) is reported. Levels of l-methyluracil and 1–4 in platinum-l-methyluracil blue (PtMeUB) have been assessed by high performance liquid chromatography (HPLC). This technique has also been used to show that in physiological saline or water, PtMeUB hydrolyzes to 3 or 4, respectively. Visible spectroscopy shows that the rate of hydrolysis of PtMeUB is much faster in fetal calf serum than in saline or water, with HPLC indicating that the product of hydrolysis in serum is 3. The precipitate obtained upon treatment of DNA solutions with PtMeUB has also been shown to hydrolyze to 3 or 4 when suspended in saline or water. Compounds 1–3 have been tested against the Ascites S-180J tumors, with 2 and 3 being active, while 4 has been shown to react readily with DNA. Possible mechanisms of antitumor action of PtMeUB that involve 3 and 4 are proposed.     

Reactions of CO2 with tetrahydroborato copper(I) complexes in moist solvents: Synthesis and reactions of [(phen)2Cu] [(HO)3B(O2CH)] and (phen)(Ph3P)Cu(O2COH) (phen = 1,10-phenanthroline)

Carbon dioxide reacts with the tetrahydroborato copper(I) complex, (phen)(Ph₃P)Cu(BH₄) (phen = 1,10-phenanthroline) (1) in moist tetrahydrofuran and in the presence of free phen affording the ionic derivative [(phen)₂Cu] [(HO)₃B(O₂CH)] (3). The same complex 3 can be obtained from 1 and aqueous formic acid in the presence of phen; from the new tetrahydroborato copper(I) complex, (phen)₂Cu(BH₄) (2), and aqueous formic acid; and from 2 with CO₂ in moist tetrahydrofuran.The reaction of (phen)(Ph₃P)Cu(BH₄) (1) with CO₂ in moist methanol gives the bicarbonato derivative, (phen)(Ph₃P)Cu(O₂COH) (4). The action of alcohols, ROH, on 3 causes the formation of the ionic formato complex [(phen)₂Cu](O₂CH) (5), the boron atom being eliminated as the alkyl boric ester, (RO)₃B. Complex 3 reacts with an alcoholic triphenylphosphine solution giving the already reported covalent formato derivative, (phen)(Ph₃P)Cu(O₂CH). The reaction of 3 with PhCH₂Br gives the benzyl formic ester HCO₂CH₂Ph. The reactivity of 4 toward neutral ligands such as phen and CyNC has been investigated, the ionic bicarbonato derivatives, [(phen)₂Cu](HCO₃) (8) and [(phen)(CyNC)₂Cu](HCO₃) (9), being obtained respectively.     

Synthesis and antinociceptive properties of N-phenyl-N-(1-(2-(thiophen-2-yl)ethyl)azepane-4-yl)propionamide in the mouse tail-flick and hot-plate tests

The goals of this study, were to synthesize N-phenyl-N-(1-(2-(thiophen-2-yl)ethyl)azepane-4-yl)propionamide (1c) and determine its antinociceptive properties. The effect of clonidine on 1c antinociception and the involvement of opioid, α₂-adrenergic, and I₂ imidazoline receptors in 1c antinociception were studied. Also examined was the effect of an endothelin ET_A receptor antagonist on 1c antinociception. Synthesis of 1c was accomplished in two steps using modifications of previously reported methods. Antinociceptive (tail-flick and hot-plate) latencies were measured in male Swiss Webster mice treated with 1c; antagonists + 1c; clonidine + 1c; or antagonists + clonidine + 1c. Mice were pretreated with naloxone (opioid antagonist), yohimbine (α₂-adrenoceptor antagonist), idazoxan (α₂-adrenoceptor/I₂-imidazoline antagonist), BU224 (I₂-imidazoline antagonist) or BQ123 (endothelin ET_A receptor antagonist) to study the involvement of these receptors. Compound 1c produced a dose-dependent increase in antinociceptive latencies; ED₅₀ values were 0.15 mg/kg and 0.16 mg/kg, respectively, in the tail flick and hot plate tests. Naloxone, but not yohimbine, idazoxan or BU224, blocked 1c antinociception. Neither clonidine nor BQ123 potentiated 1c antinociception. Results demonstrate that 1c is 15-times more potent than morphine. The antinociceptive effect of 1c is mediated through opioid receptors. The α₂-adrenergic, I₂-imidazoline and endothelin ET_A receptors are not involved in 1c antinociception.     

Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists

Novel 2-thioxothiazole derivatives (6–19) as potential adenosine A_2A receptor (A_2AR) antagonists were synthesized. The strong interaction of the compounds (6–19) with A_2AR in docking study was confirmed by high binding affinity with human A_2AR expressed in HEK293T cells using radioligand-binding assay. The compound 19 demonstrated very high selectivity for A_2AR as compared to standard A_2AR antagonist SCH58261. Decrease in A_2AR-coupled release of endogenous cAMP in treated HEK293T cells demonstrated in vitro A_2AR antagonist potential of the compound 19. Attenuation in haloperidol-induced impairment (catalepsy) in Swiss albino male mice pre-treated with compound 19 is evocative to explore its prospective in therapy of PD.     

The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5

The oxidative cyclization of 2′-hydroxy-6′-cyclohexylmethoxychalcones 5 using thallium (III) nitrate (TTN) in alcoholic solvents produced isoflavones 2 and (or) aurones 3 depending on the electronic nature of p-substituents on ring B. Chalcones with strong electron donating substituents (OH, OCH₃) were exclusively converted to isoflavones 2. Chalcone with weak electron donating substituents (CH₂CH₃) was transformed into isoflavone 2 and the aurone 3 in approximate ratio 1:1. Chalcones with hydrogen or electron withdrawing substituents (Cl, CHO, COOCH₃, and NO₂) formed aurones 3. Synthesized isoflavones 2 and aurones 3 were evaluated for their inhibitory activity against interleukin-5. Among them, 5-(cyclohexylmethoxy)-3-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (2h, >100% inhibition at 50 μM, IC₅₀ = 6.1 μM) gave most potent activity. All the aurones 3 were inactive.     

New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation

We previously reported bifunctional sigma-1 (σ₁) ligands endowed with antioxidant activity (1 and 2). In the present paper, pure enantiomers (R)-1 and (R)-2 along with the corresponding p-methoxy (6, 11), p-fluoro derivatives (7, 12) were synthesized. σ₁ and σ₂ affinities, antioxidant properties, and chemico-physical profiles were evaluated. Para derivatives, while maintaining strong σ₁ affinity, displayed improved σ₁ selectivity compared to the parent compounds 1 and 2. In vivo evaluation of compounds 1, 2, (R)-1, 7, and 12 showed σ₁ agonist pharmacological profile. Chemico-physical studies revealed that amides 2, 11 and 12 were more stable than corresponding esters 1, 6 and 7 under our experimental conditions. Antioxidant properties were exhibited by fluoro derivatives 7 and 12 being able to increase total antioxidant capacity (TAC). Our results underline that p-substituents have an important role on σ₁ selectivity, TAC, chemical and enzymatic stabilities. In particular, our data suggest that new very selective compounds 7 and 12 could be promising tools to investigate the disorders in which σ₁ receptor dysfunction and oxidative stress are contemporarily involved.     

Synthesis of tricyclic fused coumarin sulfonates and their inhibitory effects on LPS-induced nitric oxide and PGE2 productions in RAW 264.7 macrophages

The regulations of NO and PGE₂ productions are research topics of interest in the field of antiinflammatory drug development. In the present study, a series of tricyclic fused coumarin sulfonate derivatives was synthesized and evaluated for their abilities to inhibit NO and PGE₂ productions in LPS-induced RAW 264.7 macrophages. Among all the target compounds, compound 1g possessing p-(trifluoromethyl)phenyl and fused cycloheptane moieties showed the highest inhibitory effects on NO and PGE₂ productions. Compound 1g not only inhibited COX-2 activity but also reduced expressions of COX-2 and iNOS. Furthermore, ADME profiling showed that compounds 1g, 1j, 1m, and 1n are estimated to be orally bioavailable.     

Antileishmanial activity and ultrastructural changes of sesquiterpene lactones isolated from Calea pinnatifida (Asteraceae)

Bioactivity-guided fractionation of antileishmanial active CH₂Cl₂ phase of MeOH extract from leaves of Calea pinnatifida led to isolation of two sesquiterpene lactones calein C (1) and calealactone C (2), which structures were stablished on the basis of spectroscopic analysis. Compounds 1 and 2 displayed potent activity against Leishmania amazonensis promastigotes with EC₅₀ of 1.7 and 4.6 µg mL⁻¹, respectively. Compound 2 presented low cytotoxicity for J774 macrophages and displayed activity against amastigote forms of L. amazonensis similar to miltefosine with CC₅₀ values of 31.73 and 27.18 µg mL⁻¹, respectively. Additionally, compounds 1 and 2 caused ultrastructural changes in promastigotes leading to a loss of their classical structural morphology, as evidenced by electron microscopy. Also compound 2 decreased the mitochondria membrane potential. To the best of our knowledge, this is the first occurrence of 1 and 2 in C. pinnatifida. The results obtained highlighted the importance of studying sesquiterpene lactones isolated from Calea pinnatifida in terms of antileishmanial activity, in order to understand the mechanism of action of the isolated compounds in promastigotes forms of L. amazonensis.